| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
136.22(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $543.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
44,753 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,062,766 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
4 |
6 |
7 |
8 |
| Total Sell Transactions |
5 |
8 |
10 |
15 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Zielinski Thomas C |
EVP & General Counsel |
• • – |
2017-03-02 |
4 |
D |
$165.97 |
$100,412 |
D/D |
(605) |
20,515 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2017-03-02 |
4 |
S |
$166.27 |
$3,814,062 |
D/D |
(22,936) |
21,120 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2017-03-02 |
4 |
OE |
$108.35 |
$3,074,777 |
D/D |
22,936 |
44,056 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2017-03-02 |
4 |
D |
$165.97 |
$21,410 |
D/D |
(129) |
23,701 |
|
- |
|
| Haytaian Peter D |
EVP & President, GBD |
• • – |
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,867 |
49,926 |
|
- |
|
| Haytaian Peter D |
EVP & President, GBD |
• • – |
2017-03-01 |
4 |
D |
$166.97 |
$117,881 |
D/D |
(706) |
45,059 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,744 |
21,120 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2017-03-01 |
4 |
D |
$166.97 |
$93,336 |
D/D |
(559) |
17,376 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,867 |
23,830 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2017-03-01 |
4 |
D |
$166.97 |
$27,550 |
D/D |
(165) |
18,963 |
|
- |
|
| Tomas Jose D. |
EVP & Chief HR Officer |
• • – |
2017-01-09 |
4 |
AS |
$142.92 |
$928,980 |
D/D |
(6,500) |
23,913 |
|
- |
|
| Haytaian Peter D |
EVP & President, GBD |
• • – |
2016-12-14 |
4 |
D |
$144.69 |
$94,627 |
D/D |
(654) |
45,765 |
|
- |
|
| Swedish Joseph |
Chair, President & CEO |
• • – |
2016-12-12 |
4 |
AS |
$143.44 |
$1,178,150 |
D/D |
(8,176) |
71,034 |
|
- |
|
| Tomas Jose D. |
EVP & Chief HR Officer |
• • – |
2016-12-02 |
4 |
D |
$145.10 |
$151,339 |
D/D |
(1,043) |
30,413 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2016-11-22 |
4 |
S |
$138.29 |
$113,398 |
D/D |
(820) |
1,320 |
|
- |
|
| Swedish Joseph |
Chair, President & CEO |
• • – |
2016-11-11 |
4 |
AS |
$134.44 |
$1,098,509 |
D/D |
(8,171) |
79,210 |
|
- |
|
| Swedish Joseph |
Chair, President & CEO |
• • – |
2016-11-10 |
4 |
AS |
$130.00 |
$2,124,460 |
D/D |
(16,342) |
87,381 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• • – |
2016-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
509 |
45,749 |
|
- |
|
| Samitt Craig E |
EVP & Chief Clinical Officer |
• • – |
2016-10-03 |
4 |
D |
$122.90 |
$33,920 |
D/D |
(276) |
6,408 |
|
- |
|
| Swedish Joseph |
Chair, President & CEO |
• • – |
2016-08-12 |
4 |
AS |
$130.36 |
$1,065,241 |
D/D |
(8,171) |
103,723 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• • – |
2016-08-12 |
4 |
AS |
$130.00 |
$78,000 |
D/D |
(600) |
45,240 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• • – |
2016-08-12 |
4 |
OE |
$89.44 |
$53,664 |
D/D |
600 |
45,840 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2016-08-10 |
4 |
S |
$128.83 |
$676,873 |
D/D |
(5,254) |
17,935 |
|
- |
|
| Griffin Brian T |
EVP & President, CSBD |
• • – |
2016-08-03 |
4 |
D |
$127.87 |
$27,236 |
D/D |
(213) |
28,452 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2016-08-03 |
4 |
S |
$128.37 |
$70,860 |
D/D |
(552) |
2,140 |
|
- |
|
1950 Records found
|
|
Page 18 of 78 |
|
|
6.09 (1.11%) 
